Chemotherapy and Tinnitus: What Cisplatin Does to Hearing

The article on ototoxic medications covers a range of drugs linked to tinnitus in general terms. Cisplatin, a chemotherapy drug used for testicular, ovarian, lung, and several other cancers, deserves its own article — the numbers involved are large enough, and specific enough, to be worth understanding on their own.

How common this actually is

A study of 145 testicular cancer survivors who received cisplatin-based chemotherapy found 74% reported some form of ototoxicity — hearing loss and/or tinnitus — with 68% specifically reporting tinnitus and 59% reporting hearing loss (52% had both). A separate, larger study of 243 testicular cancer survivors found broadly consistent numbers: hearing loss in 56.4% and tinnitus in 60.5%. These aren't small or unusual side-effect rates — for a substantial share of patients receiving cisplatin, tinnitus is closer to an expected outcome than a rare complication.

It's genuinely dose-dependent

Research consistently identifies cumulative cisplatin dose as a significant, measurable risk factor — more total cisplatin over the course of treatment means higher ototoxicity risk. One study also found tinnitus specifically associated with age at the time of the survey and with a history of noise exposure, meaning the risk isn't uniform across all patients receiving the same treatment; some combination of dose, age, and prior noise history shapes who's more likely to be affected. Official prescribing information for cisplatin describes the ototoxicity as cumulative and potentially severe, affecting the high-frequency range (4,000–8,000 Hz) initially, sometimes progressing to affect the ability to hear normal conversational tones at higher doses.

Why this happens

Cisplatin's ototoxic mechanism is different from most other causes covered on this site — it's directly toxic to cochlear hair cells, and research has found cisplatin is retained in the cochlea indefinitely following chemotherapy, meaning its effect on the inner ear isn't a temporary exposure that clears from the body the way many drugs do. This helps explain why cisplatin-related hearing loss and tinnitus are frequently permanent rather than resolving after treatment ends, unlike some of the more reversible medication-related causes covered in the general ototoxic medications article.

Not just a side note — a real quality-of-life impact

A study using validated functional-impairment questionnaires (not just yes/no symptom checklists) found one in three testicular cancer survivors with hearing loss reported clinically significant functional impairment from it, and the same research noted hearing loss is independently recognized as the largest modifiable risk factor for cognitive decline and dementia in the general population — a reason the researchers specifically recommended routine audiological assessment for cisplatin-treated survivors, not just symptom management after the fact.

What this means if you're facing cisplatin treatment

This isn't a reason to avoid a cancer treatment that may be the most effective option available — that's a decision between you and your oncologist, weighing cancer treatment efficacy against a real but generally non-life-threatening side effect. What it does mean:

• Baseline and follow-up hearing tests are a reasonable thing to ask for before, during, and after treatment, since audiometric monitoring is specifically recommended in clinical guidance for cisplatin
• Mentioning any history of significant noise exposure to your oncology team, since it's an identified risk factor that may factor into monitoring decisions
• Not assuming tinnitus during or after treatment is unrelated to the chemotherapy — it's a recognized, well-documented effect, not something to dismiss or feel you need to downplay

The practical takeaway

If you're a cancer survivor who received cisplatin and have tinnitus, you're not alone in that combination — it affects a majority of patients who receive this specific drug, and it's a legitimate topic to raise with both your oncology team and an audiologist, using the same management approaches (sound therapy, CBT, hearing aids where relevant) covered throughout this site, since the underlying cause being chemotherapy doesn't change what actually helps manage the tinnitus itself.